来自MSN

FDA launches pilot for real-time clinical trial oversight

The US Food and Drug Administration has begun a pilot program to test real-time clinical trial oversight, starting with two oncology studies from AstraZeneca and Amgen. Using Paradigm Health’s SPIRE ...
来自MSN

FDA pilots AI-driven real-time monitoring in drug trials

The FDA has launched proof-of-concept studies to test continuous, AI-enabled data feeds from clinical trials, aiming to replace delayed, periodic safety reporting. AstraZeneca and Amgen are running ...